184 related articles for article (PubMed ID: 20656185)
21. Platelet Transfusions in Patients with Hypoproliferative Thrombocytopenia: Conclusions from Clinical Trials and Current Controversies.
Crighton GL; Estcourt LJ; Wood EM; Stanworth SJ
Hematol Oncol Clin North Am; 2016 Jun; 30(3):541-60. PubMed ID: 27112995
[TBL] [Abstract][Full Text] [Related]
22. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
[TBL] [Abstract][Full Text] [Related]
23. Platelet transfusions for patients with haematological malignancies: who needs them?
Estcourt LJ; Stanworth SJ; Murphy MF
Br J Haematol; 2011 Aug; 154(4):425-40. PubMed ID: 21615375
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic platelet transfusions: should they be a treatment of the past?
Zeller MP; Al-Habsi KS; Heddle NM
Curr Opin Hematol; 2014 Nov; 21(6):521-7. PubMed ID: 25203535
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.
Campbell HE; Estcourt LJ; Stokes EA; Llewelyn CA; Murphy MF; Wood EM; Stanworth SJ;
Transfusion; 2014 Oct; 54(10):2394-403. PubMed ID: 24826894
[TBL] [Abstract][Full Text] [Related]
26. Different Platelet Count Thresholds to Guide Use of Prophylactic Platelet Transfusions for Patients With Hematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation.
Estcourt LJ; Stanworth SJ; Murphy MF
JAMA Oncol; 2016 Aug; 2(8):1091-2. PubMed ID: 27415031
[TBL] [Abstract][Full Text] [Related]
27. Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia.
Estcourt LJ; Desborough M; Hopewell S; Doree C; Stanworth SJ
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011771. PubMed ID: 26627708
[TBL] [Abstract][Full Text] [Related]
28. Prophylactic platelet transfusion prior to central venous catheter placement in patients with thrombocytopenia: study protocol for a randomised controlled trial.
van de Weerdt EK; Biemond BJ; Zeerleder SS; van Lienden KP; Binnekade JM; Vlaar APJ;
Trials; 2018 Feb; 19(1):127. PubMed ID: 29463280
[TBL] [Abstract][Full Text] [Related]
29. Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia.
Wandt H; Frank M; Ehninger G; Schneider C; Brack N; Daoud A; Fackler-Schwalbe I; Fischer J; Gäckle R; Geer T; Harms P; Löffler B; Ohl S; Otremba B; Raab M; Schönrock-Nabulsi P; Strobel G; Winter R; Link H
Blood; 1998 May; 91(10):3601-6. PubMed ID: 9572994
[TBL] [Abstract][Full Text] [Related]
30. Platelets for neonatal transfusion - study 2: a randomised controlled trial to compare two different platelet count thresholds for prophylactic platelet transfusion to preterm neonates.
Curley A; Venkatesh V; Stanworth S; Clarke P; Watts T; New H; Willoughby K; Khan R; Muthukumar P; Deary A
Neonatology; 2014; 106(2):102-6. PubMed ID: 24851997
[TBL] [Abstract][Full Text] [Related]
31. Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study.
Tay J; Allan D; Beattie S; Bredeson C; Fergusson D; Maze D; Sabloff M; Thavorn K; Tinmouth A
BMJ Open; 2016 Oct; 6(10):e013483. PubMed ID: 27798034
[TBL] [Abstract][Full Text] [Related]
32. Compliance with prophylactic platelet transfusion trigger in haematological patients.
Eikenboom JC; van Wordragen R; Brand A
Transfus Med; 2005 Feb; 15(1):45-8. PubMed ID: 15713128
[TBL] [Abstract][Full Text] [Related]
33. Platelet transfusions in haematologic malignancies in the last six months of life.
Moracchini J; Seigeot A; Angelot-Delettre F; Vienot A; Aubry R; Daguindau É; Deconinck E; Frache S; Tiberghien P
Vox Sang; 2021 Apr; 116(4):425-433. PubMed ID: 32790960
[TBL] [Abstract][Full Text] [Related]
34. Randomized Trial of Platelet-Transfusion Thresholds in Neonates.
Curley A; Stanworth SJ; Willoughby K; Fustolo-Gunnink SF; Venkatesh V; Hudson C; Deary A; Hodge R; Hopkins V; Lopez Santamaria B; Mora A; Llewelyn C; D'Amore A; Khan R; Onland W; Lopriore E; Fijnvandraat K; New H; Clarke P; Watts T;
N Engl J Med; 2019 Jan; 380(3):242-251. PubMed ID: 30387697
[TBL] [Abstract][Full Text] [Related]
35. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
Slichter SJ
J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
[TBL] [Abstract][Full Text] [Related]
36. Platelet transfusion goals in oncology patients.
Fasano RM; Josephson CD
Hematology Am Soc Hematol Educ Program; 2015; 2015():462-70. PubMed ID: 26637759
[TBL] [Abstract][Full Text] [Related]
37. Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia.
Apelseth TO; Hervig T; Bruserud O
Blood Rev; 2011 May; 25(3):113-22. PubMed ID: 21316823
[TBL] [Abstract][Full Text] [Related]
38. Optimizing platelet transfusion therapy.
Heal JM; Blumberg N
Blood Rev; 2004 Sep; 18(3):149-65. PubMed ID: 15183900
[TBL] [Abstract][Full Text] [Related]
39. The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study.
Vijenthira A; Premkumar D; Callum J; Lin Y; Wells RA; Chodirker L; Lenis M; Mamedov A; Buckstein R
Leuk Res; 2019 Jan; 76():76-81. PubMed ID: 30580105
[TBL] [Abstract][Full Text] [Related]
40. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions.
Friedmann AM; Sengul H; Lehmann H; Schwartz C; Goodman S
Transfus Med Rev; 2002 Jan; 16(1):34-45. PubMed ID: 11788928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
